MB
PFE icon

MidFirst Bank’s Pfizer PFE Stock Holding History

MidFirst Bank’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Buy
6,366
+39
+0.6% +$1.02K 0.01% 305
2026
Q1 		$178K Sell
6,327
-1,684
-21% -$44.8K 0.01% 288
2025
Q4 		$199K Buy
+8,011
New +$202K 0.02% 335

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MidFirst Bank's PFE Position: Q2 2026 in Review

MidFirst Bank increased its Pfizer (PFE) stake by 0.62% in Q2 2026, buying an estimated $1.02K and bringing the position to 6,366 shares worth $153K. The position accounts for 0.01% of the portfolio, ranked #305.

MidFirst Bank first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $199K in Q4 2025. 2,472 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MidFirst Bank held 6,366 shares of Pfizer worth $153K as of Q2 2026.
  • MidFirst Bank bought 39 Pfizer shares in Q2 2026, an estimated $1.02K.
  • Pfizer made up 0.01% of MidFirst Bank's portfolio in Q2 2026, its #305 holding.
  • MidFirst Bank first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • MidFirst Bank's Pfizer position peaked at $199K in Q4 2025.
  • 2,472 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.